This session will examine disparities in HIV prevention and
transmission among Black/African-American cisgender women and discuss
effective strategies and approaches to prescribing pre-exposure
- Describe disparities in HIV prevention and transmission among
Black and African/American cisgender women.
- Review pre-prescription screening and FDA-approved options for HIV PrEP.
- Discuss best practices for patient monitoring and clinical management.